Associated tags: PALM, News, USD, TSX
Locations: AR, CR, BONE, NOVA, KRAS, NUNAVUT, BROOKFIELD, EUROPE, ENGLAND, LONDON, ILIAD, SOUTH AMERICA, CU, RIO, PORTUGAL, BRAZIL, ALASKA, ARIZONA, CHILE, AURORA, SWEDEN, PK, RARE, IV, WALES, GRANDVIEW, ALBERTA, NAMIBIA, SOUTH AUSTRALIA, LIBERTAD, LIMON, TESLA, COLUMBUS, NEVADA, RUGBY, MANCHESTER, MOZAMBIQUE, NEW ZEALAND, LOS ANGELES, III, CHANNEL ISLANDS, IRELAND, OMNI, AL, SAUDI ARABIA, COLORADO, NA, LATIN AMERICA, MEXICO, COLOMBIA, GT, PRATT, GD, UTAH, CENTRAL DISTRICT, NEW YORK CITY, CHICAGO, POMPANO BEACH, FL, US, SAR, ILLINOIS, AUSTRALIA, UNITED STATES, UNITED STATES OF AMERICA, NEW YORK, UNITED KINGDOM, FLORIDA, MERCEDES, DENISON, GOLDMAN, FUKUSHIMA, SASKATCHEWAN, ONTARIO, CANADA, FORT BRAGG, NORTHROP, SOUTHAMPTON, UKRAINE, NORTH CAROLINA, MT, EU, ABERDEEN, CALIFORNIA, JAPAN, POLAND, GERMANY, ARGENTINA, TORONTO, FORT LEONARD WOOD, UNION CITY, APACHE
Retrieved on:
Tuesday, January 30, 2024
A report from Data Bridge Market Research said that the North American multiple myeloma diagnostic market which was USD 3732.64 million in 2022, is expected to reach USD 5390.01 million by 2030, at a CAGR of 4.7% during the forecast period 2023 to 2030.
Key Points:
- A report from Data Bridge Market Research said that the North American multiple myeloma diagnostic market which was USD 3732.64 million in 2022, is expected to reach USD 5390.01 million by 2030, at a CAGR of 4.7% during the forecast period 2023 to 2030.
- The report said: “The main factors driving the market growth of the multiple myeloma diagnostics market are technological advancement and rising clinical studies for the management of multiple myeloma.
- Furthermore, rising disposable income is expected to drive the growth of the multiple myeloma diagnostic market.
- Government funds and initiatives for effective research and development are assisting in the discovery of new drugs for better treatment of multiple myeloma for the multiple myeloma diagnostic market.
Retrieved on:
Wednesday, January 24, 2024
TDEM,
STUD,
Uranium,
Appaloosa,
Discovery,
UEC,
Mining,
Government,
Data,
Sale,
Ground,
TSX,
EM,
OTCQX,
Stallion,
Projection,
Anomaly,
FCU,
News,
Glacier Media,
PALM,
Uranium mining Stockhead recently trumpeted, “Uranium has started 2024 the same way it ended 2023—like a bull in a china shop.
Key Points:
- Stockhead recently trumpeted, “Uranium has started 2024 the same way it ended 2023—like a bull in a china shop.
- Furthermore, market analysts project an average supply deficit of 35 million pounds per year over the next decade.
- The latter company plans to increase its uranium production to 22 million pounds this year.
- As of early 2024, SPUT had impounded more than 63 million pounds of uranium.
Retrieved on:
Thursday, January 18, 2024
Lithium,
Well,
Dorado,
Technische Universität Darmstadt,
Ministry of home affairs,
EVS,
Government,
LANXESS,
Alberta Innovates,
Carbon,
Growth,
Sand,
Mining,
SLI,
DLE,
Transport,
PALM,
Citigroup,
ICE,
Gold,
Investment,
Acquisition,
Porosity,
OTCQX,
Update,
Partnership,
Electronics,
Salar del Hombre Muerto,
OTCQB,
News,
BNP Paribas,
USD,
PEA,
Tablet Government subsidies for EVs, along with investments in this space, are likely to act as an additional booster to market growth.
Key Points:
- Government subsidies for EVs, along with investments in this space, are likely to act as an additional booster to market growth.
- The Grand View Research report added: “The market is characterized by a high degree of innovation to optimize both the manufacturing process, and also obtain high purity lithium.
- Players have invested in R&D heavily to optimize the usage of lithium in high-growth end use segments such as electric vehicles.
- The lithium market is at a high stage of growth, with an accelerated pace.
Retrieved on:
Wednesday, January 17, 2024
Probability,
UXC,
Mergers and acquisitions,
Luce Irigaray,
Federal,
Power plant engineering,
Sale,
Carbon,
TSX Venture Exchange,
NXE,
Soil,
Growth,
FUU,
Void coefficient,
PLN,
Spin-off (media),
UEC,
Mining,
Environment,
ISR,
Murphy Lake,
Indian stock exchange,
PALM,
Athabasca,
STUD,
Arrangement,
CFT,
Powder River Basin,
Conventional weapon,
TSX,
Water,
Nuclear energy,
Nuclear fission,
SASK,
Agent,
OTCQB,
Canada Business Corporations Act,
Stallion,
Broach,
News,
Arrow,
Uranium mining The construction and expansion of nuclear power plants lead to increased uranium demand, driving uranium mining activities.
Key Points:
- The construction and expansion of nuclear power plants lead to increased uranium demand, driving uranium mining activities.
- The report says: “The global uranium mining market is expected to reach US$ 11,388.3 million by 2030, with an annual growth rate of more than 5.0%.
- The uranium mining market is estimated to be 53.0 thousand tons (kt) in 2023.
- Based on the mining method, the open-pit mining segment is the most common method of uranium mining, accounting for over 90% of global uranium production in 2022.
Retrieved on:
Wednesday, January 24, 2024
Teaching hospital,
Research,
Anxiety,
Life,
Benzodiazepine,
MADRS,
MindMed,
NEO,
Diagnosis,
Depression,
Growth,
Therapy,
Disorder,
Psilocybin,
Hackensack Meridian Health,
Safety,
DSM-IV codes,
Phase,
PALM,
GAD,
Buspirone,
Mental health,
PD,
University Hospital of Basel,
Quality of life,
Call-progress tone,
CMPS,
Patient,
Generalized anxiety disorder,
Food,
HMH,
FDA,
EU4,
Anticonvulsant,
DMT,
News,
Pharmaceutical industry PALM BEACH, Fla., Jan. 24, 2024 /PRNewswire/ -- The coming years could see a massive shift in the U.S. government's approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD). GAD is a prevalent mental health condition characterized by excessive and persistent worry, often extending beyond specific triggers. Individuals with GAD experience heightened levels of anxiety, anticipating future events and exhibiting physical symptoms such as muscle tension and restlessness. The disorder significantly impairs daily functioning and quality of life. A report from Delveinsight said that the total market size of the Generalized Anxiety Disorder (GAD) treatment market is anticipated to experience growth during the forecast period (2032) due to the emergence of new and effective treatments, especially numerous trials developing new and innovative next-generation psychedelic treatment options. The report added: "The diagnosis of Generalized Anxiety Disorder (GAD) involves a comprehensive assessment of an individual's mental health, considering the presence of excessive and uncontrollable worry across various aspects of life for a minimum of six months. Clinicians utilize standardized psychiatric interviews and validated screening tools to evaluate the severity of anxiety symptoms, along with a thorough exploration of associated physical and psychological manifestations. Differential diagnosis is crucial to rule out other psychiatric conditions, medical disorders, or substance-related issues that may mimic GAD symptoms. The diagnostic process also entails considering the impact of anxiety on daily functioning and its persistence in the absence of identifiable stressors. A multidimensional approach aids in ensuring an accurate diagnosis and facilitates the development of an effective treatment plan tailored to the individual's needs." Active Companies active today in markets include: Cybin Inc. (NYSE: CYBN) (NEO: CYBN), COMPASS Pathways plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), Seelos Therapeutics, Inc. (NASDAQ: SEEL), atai Life Sciences (NASDAQ: ATAI).
Key Points:
- Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD).
- It continued: "DelveInsight's analyst projects that among the total diagnosed prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM approximately 53% of cases were from the US.
- The Generalized Anxiety Disorder (GAD) market is projected to witness consistent growth throughout the forecast period (2023–2032).
- The market size of Generalized Anxiety Disorder (GAD) in the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies."
Retrieved on:
Wednesday, January 24, 2024
Teaching hospital,
Research,
Anxiety,
Life,
Benzodiazepine,
MADRS,
MindMed,
NEO,
Diagnosis,
Depression,
Growth,
Therapy,
Disorder,
Psilocybin,
Hackensack Meridian Health,
Safety,
DSM-IV codes,
Phase,
PALM,
GAD,
Buspirone,
Mental health,
PD,
University Hospital of Basel,
Quality of life,
Call-progress tone,
CMPS,
Patient,
Generalized anxiety disorder,
Food,
HMH,
FDA,
EU4,
Anticonvulsant,
DMT,
News,
Pharmaceutical industry PALM BEACH, Fla., Jan. 24, 2024 /PRNewswire/ -- The coming years could see a massive shift in the U.S. government's approach to regulating hallucinogenic drugs. Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD). GAD is a prevalent mental health condition characterized by excessive and persistent worry, often extending beyond specific triggers. Individuals with GAD experience heightened levels of anxiety, anticipating future events and exhibiting physical symptoms such as muscle tension and restlessness. The disorder significantly impairs daily functioning and quality of life. A report from Delveinsight said that the total market size of the Generalized Anxiety Disorder (GAD) treatment market is anticipated to experience growth during the forecast period (2032) due to the emergence of new and effective treatments, especially numerous trials developing new and innovative next-generation psychedelic treatment options. The report added: "The diagnosis of Generalized Anxiety Disorder (GAD) involves a comprehensive assessment of an individual's mental health, considering the presence of excessive and uncontrollable worry across various aspects of life for a minimum of six months. Clinicians utilize standardized psychiatric interviews and validated screening tools to evaluate the severity of anxiety symptoms, along with a thorough exploration of associated physical and psychological manifestations. Differential diagnosis is crucial to rule out other psychiatric conditions, medical disorders, or substance-related issues that may mimic GAD symptoms. The diagnostic process also entails considering the impact of anxiety on daily functioning and its persistence in the absence of identifiable stressors. A multidimensional approach aids in ensuring an accurate diagnosis and facilitates the development of an effective treatment plan tailored to the individual's needs." Active Companies active today in markets include: Cybin Inc. (NYSE: CYBN) (NEO: CYBN), COMPASS Pathways plc (NASDAQ: CMPS), Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED), Seelos Therapeutics, Inc. (NASDAQ: SEEL), atai Life Sciences (NASDAQ: ATAI).
Key Points:
- Several biopharma companies are developing psychedelics-based treatments for various mental health conditions like Generalized Anxiety Disorder (GAD).
- It continued: "DelveInsight's analyst projects that among the total diagnosed prevalent cases of Generalized Anxiety Disorder (GAD) in 7MM approximately 53% of cases were from the US.
- The Generalized Anxiety Disorder (GAD) market is projected to witness consistent growth throughout the forecast period (2023–2032).
- The market size of Generalized Anxiety Disorder (GAD) in the 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies."
Retrieved on:
Tuesday, January 16, 2024
Dorado,
NPV,
Party,
Government,
LANXESS,
Carbon,
Denison Mines,
Growth,
Agreement,
Option,
IRR,
Mining,
SLI,
DLE,
GLC,
PALM,
GRD,
Citigroup,
Outline,
TSX,
KLP,
OTCQX,
Exercise,
DNN,
Professional,
Partnership,
Long-Term Capital Management,
Contract management,
OTCQB,
USD,
EV,
LCE,
PEA,
Miner,
EMP,
News,
Lithium Lithium mining remains a prominent area of investment as lithium batteries are used in electric vehicles, battery powered machinery, and others.
Key Points:
- Lithium mining remains a prominent area of investment as lithium batteries are used in electric vehicles, battery powered machinery, and others.
- With a significant increase in the production of electric vehicles, the demand for lithium has significantly increased in recent years.
- The majority of the lithium produced is consumed for rechargeable batteries used in electric vehicles; according to estimates, batteries account for 46% of all lithium consumption worldwide.
- Hence, the flourishing lithium-ion batteries demand propels the growth of the lithium mining sector.
Retrieved on:
Thursday, January 11, 2024
EVS,
Lundin Mining,
FWB,
Knowledge,
Silver,
Table,
3D,
VMS,
Construction,
Rio Tinto,
Technical report,
LUMI,
Learning,
Heart,
Culture,
Zone,
Mining,
Copper,
Zinc,
Disclosure,
Porcupine,
MOST,
Transport,
Lens,
PALM,
Nickel,
Senior,
Oyu Tolgoi mine,
MRE,
Rio Tinto (corporation),
Developed country,
Gold,
TSX,
Technical,
OTCQX,
FIL,
Exercise,
Filo,
JDS,
Haines Borough, Alaska,
Electronics,
FCX,
News,
LUN,
Urbanization,
Molybdenum,
Project,
ITS A report from Fortune Business Insights said that the global copper mining market size, which was valued at USD 8.44 billion in 2022 is projected to grow from USD 8.87 billion in 2023 to USD 11.17 billion by 2030, exhibiting a CAGR of 3.3% during the forecast period.
Key Points:
- A report from Fortune Business Insights said that the global copper mining market size, which was valued at USD 8.44 billion in 2022 is projected to grow from USD 8.87 billion in 2023 to USD 11.17 billion by 2030, exhibiting a CAGR of 3.3% during the forecast period.
- Copper is essential for constructing infrastructure projects such as buildings, bridges, and electrical systems.
- Hence, government initiatives and policies promoting infrastructure development can significantly boost the market.
- The mining industry, mainly of copper, will likely increase significantly due to increased investment in construction and construction projects.
Retrieved on:
Thursday, January 11, 2024
Lithium,
EVS,
Research,
Electricity,
Deposit,
Carbon,
Livent,
Technical report,
Growth,
ESM,
Gasoline,
POSCO,
DLE,
PALM,
Smartphone,
MRE,
NewCo,
Resource,
Executive,
TSX,
Water,
National instrument,
Port,
Partnership,
OTCQB,
News,
Separation,
Interim,
LAAC,
Project,
PEA,
Q3 The global lithium market size is expected to see strongly grown in the next few years.
Key Points:
- The global lithium market size is expected to see strongly grown in the next few years.
- Major trends in the forecast period include advancements in lithium technologies, solid-state lithium batteries, diversification of lithium sources, integration of lithium in aerospace, and decentralized energy solutions.
- An increase in smartphone adoption is expected to propel the growth of the lithium market going forward.
- The report continued: “The increasing demand for electric vehicles is expected to propel the growth of the lithium market going forward.
Retrieved on:
Thursday, January 11, 2024
Beer,
Skin care,
Pacific Northwest,
CGC,
Sale,
DSM-IV codes,
TLRY,
Lead,
United States farm bill,
Growth,
Drink,
Food,
Sleep,
Tilray,
CPG,
Cosmetics,
Uncle,
Snack,
PALM,
ASX,
Brink's,
Mental health,
Acquisition,
Cannabis,
OTCQX,
Tobacco,
Marketing,
Smoke,
Patient,
Canopy Growth,
Health,
Oil,
Digital,
OTCQB,
News,
Intellectual property,
Drug A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.
Key Points:
- A report from The Brightfield Group said: “It is no surprise to see that CBD is expected to grow to $16 billion by 2025.
- Especially as we see people turning to various CBD products for stress management or to promote better sleep.
- What is most notable is that this market has grown almost exclusively based on word-of-mouth.
- Canada saw over $3 billion in CBD revenue in 2020 from various products ranging from prerolls, oils, edibles, brinks, and vapes.
